SynthesisFrontiers in medicine2025

Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients.

Mulham Kalantan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.